Shares of BTG plc (LON:BTG – Get Rating) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 840 ($10.24) and traded as high as GBX 840 ($10.24). BTG shares last traded at GBX 840 ($10.24), with a volume of 271,742 shares trading hands.
BTG Stock Up 0.1 %
The stock has a 50 day simple moving average of GBX 840 and a 200 day simple moving average of GBX 840. The company has a market capitalization of £3.26 billion and a price-to-earnings ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Further Reading
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
